CENTONZE, DIEGO
 Distribuzione geografica
Continente #
NA - Nord America 135.762
EU - Europa 9.720
AS - Asia 6.457
SA - Sud America 80
Continente sconosciuto - Info sul continente non disponibili 58
OC - Oceania 39
AF - Africa 18
Totale 152.134
Nazione #
US - Stati Uniti d'America 135.663
SG - Singapore 2.736
UA - Ucraina 1.792
CN - Cina 1.769
KR - Corea 1.531
IE - Irlanda 1.474
IT - Italia 1.428
DE - Germania 1.401
RU - Federazione Russa 757
SE - Svezia 631
GB - Regno Unito 592
FR - Francia 503
FI - Finlandia 410
PL - Polonia 293
NL - Olanda 142
CA - Canada 75
JP - Giappone 71
ID - Indonesia 64
CZ - Repubblica Ceca 57
HK - Hong Kong 56
BE - Belgio 53
IN - India 52
EU - Europa 51
BR - Brasile 42
IR - Iran 35
AU - Australia 34
RO - Romania 32
BG - Bulgaria 31
ES - Italia 26
CL - Cile 23
VN - Vietnam 20
KG - Kirghizistan 17
AT - Austria 16
UZ - Uzbekistan 15
DK - Danimarca 14
DM - Dominica 14
IL - Israele 12
CH - Svizzera 10
TR - Turchia 10
GR - Grecia 9
MX - Messico 9
PH - Filippine 9
PT - Portogallo 9
HR - Croazia 8
TW - Taiwan 8
A2 - ???statistics.table.value.countryCode.A2??? 7
AE - Emirati Arabi Uniti 7
SA - Arabia Saudita 7
HU - Ungheria 6
KZ - Kazakistan 6
LT - Lituania 6
MY - Malesia 6
PE - Perù 6
ZA - Sudafrica 6
AR - Argentina 5
EG - Egitto 5
NO - Norvegia 5
NZ - Nuova Zelanda 5
BD - Bangladesh 4
LA - Repubblica Popolare Democratica del Laos 4
RS - Serbia 4
IQ - Iraq 3
KH - Cambogia 3
MA - Marocco 3
NG - Nigeria 3
TH - Thailandia 3
AZ - Azerbaigian 2
CO - Colombia 2
KW - Kuwait 2
LK - Sri Lanka 2
LV - Lettonia 2
SM - San Marino 2
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BO - Bolivia 1
EC - Ecuador 1
EE - Estonia 1
ET - Etiopia 1
JO - Giordania 1
MD - Moldavia 1
MF - Saint Martin 1
MT - Malta 1
PK - Pakistan 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
VA - Santa Sede (Città del Vaticano) 1
Totale 152.134
Città #
Woodbridge 39.448
Wilmington 38.071
Houston 32.991
Fairfield 4.497
Ann Arbor 3.281
Singapore 2.402
Ashburn 1.879
Seattle 1.783
Chandler 1.766
Jacksonville 1.595
Cambridge 1.538
Dublin 1.420
Medford 1.027
Beijing 593
Santa Clara 562
Dearborn 561
Lawrence 487
New York 483
Rome 416
Zhengzhou 349
Kraków 274
Hangzhou 269
Mülheim 241
San Diego 236
Menlo Park 200
Norwalk 171
Milan 132
Redwood City 107
London 102
Moscow 92
Munich 85
San Mateo 85
Mountain View 80
University Park 78
Shanghai 77
Falls Church 69
Guangzhou 66
Jakarta 62
Saint Petersburg 60
Verona 59
Seoul 58
Palo Alto 56
Hefei 53
Nanjing 53
Council Bluffs 52
Brno 48
Detroit 48
Brussels 46
Helsinki 45
Mcallen 45
Boardman 40
Kunming 37
Toronto 37
Philadelphia 33
Colorado Springs 31
Nanchang 31
San Francisco 31
Hong Kong 30
Lappeenranta 29
Roebling 29
Los Angeles 28
Chicago 27
Center 26
São Paulo 24
Naples 21
San Jose 21
Indiana 20
Southern 19
Hounslow 18
Redmond 18
Jinan 17
Kilburn 17
Nuremberg 17
Arosio 16
Creede 16
Nürnberg 16
Tokyo 16
Del Norte 15
Inverigo 15
Chiswick 14
Hebei 14
New Bedfont 14
Phoenix 14
Pune 14
Roseau 14
Daejeon 13
Dong Ket 13
Fuzhou 13
Prescot 13
Amsterdam 12
Atlanta 12
Chengdu 12
Paris 12
Florence 11
Hanover 11
Wuhan 11
Auburn Hills 10
Bologna 10
Frankfurt am Main 10
Islington 10
Totale 139.150
Nome #
Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression 679
Neurophysiology of synaptic functioning in multiple sclerosis 513
Cannabinoids therapeutic use: what is our current understanding following the introduction of THC, THC:CBD oromucosal spray and others? 510
Caspase-8 contributes to angiogenesis and chemotherapy resistance in glioblastoma 504
KFLC Index utility in multiple sclerosis diagnosis: Further confirmation 479
Tumor necrosis factor is elevated in progressive multiple sclerosis and causes excitotoxic neurodegeneration 477
Budget Impact Analysis for Peginterferon Beta-1a In Relapsing Remitting Multiple Sclerosis In Italy 476
Effects of postural exercises in patients with Parkinson's disease and Pisa syndrome: A pilot study 470
miR-142-3p Is a Key Regulator of IL-1β-Dependent Synaptopathy in Neuroinflammation 464
A novel crosstalk within the endocannabinoid system controls GABA transmission in the striatum 462
Abnormal mGlu 5 receptor/endocannabinoid coupling in mice lacking FMRP and BC1 RNA 460
Synaptopathy connects inflammation and neurodegeneration in multiple sclerosis 459
Neural stem cell transplantation induces stroke recovery by upregulating glutamate transporter GLT-1 in astrocytes 458
Connectivity Between Posterior Parietal Cortex and Ipsilateral Motor Cortex Is Altered in Schizophrenia 456
Growth factors and synaptic plasticity in relapsing-remitting multiple sclerosis 456
Interferon-γ causes mood abnormalities by altering cannabinoid CB1 receptor function in the mouse striatum 454
FAS-ligand regulates differential activation-induced cell death of human T-helper 1 and 17 cells in healthy donors and multiple sclerosis patients 453
No evidence of beneficial effects of plasmapheresis in natalizumab-associated PML 453
Natalizumab discontinuation in patients with multiple sclerosis: Profiling risk and benefits at therapeutic crossroads 450
A synaptic mechanism underlying the behavioral abnormalities induced by manganese intoxication 448
Abnormal Ca2+-calmodulin-dependent protein kinase II function mediates synaptic and motor deficits in experimental parkinsonism 448
Muscarinic IPSPs in rat striatal cholinergic interneurones 442
Subclinical central inflammation is risk for RIS and CIS conversion to MS 441
Genetic variants of the NMDA receptor influence cortical excitability and plasticity in humans 440
Voluntary exercise and sucrose consumption enhance cannabinoid CB1 receptor sensitivity in the striatum 438
Real-world effectiveness of natalizumab and fingolimod compared with self-injectable drugs in non-responders and in treatment-naïve patients with multiple sclerosis 438
T helper 9 cells induced by plasmacytoid dendritic cells regulate interleukin-17 in multiple sclerosis 436
TRPV1 polymorphisms and risk of interferon β-induced flu-like syndrome in patients with relapsing-remitting multiple sclerosis 436
Hypoglycemia, hypoxia, and ischemia in a corticostriatal slice preparation: electrophysiologic changes and ascorbyl radical formation 435
Treatment decisions for patients with active multiple sclerosis 435
Distinct modulation of human myeloid and plasmacytoid dendritic cells by anandamide in multiple sclerosis 433
Neuroinflammation drives anxiety and depression in relapsing-remitting multiple sclerosis 433
Chronic cocaine sensitizes striatal GABAergic synapses to the stimulation of cannabinoid CB1 receptors 432
Abnormal striatal GABA transmission in the mouse model for the fragile X syndrome 431
Gabaergic and glutamatergic synaptic transmissions are altered after cuprizone exposure: implication for schizophrenia and demyelinating diseases 431
Cortical hyperexcitability in post-traumatic stress disorder secondary to minor accidental head trauma: a neurophysiologic study 431
Siponimod (BAF312) prevents synaptic neurodegeneration in experimental multiple sclerosis 430
The cross-cultural adaptation and psychometric validation of the MSSS-88 for use in Italian patients with multiple sclerosis 429
Type-1 cannabinoid receptors colocalize with caveolin-1 in neuronal cells 426
Risk of acute promyelocytic leukemia in multiple sclerosis: coding variants of DNA repair genes 426
Placebo effects in a multiple sclerosis spasticity enriched clinical trial with the oromucosal cannabinoid spray (THC/CBD): dimension and possible causes 426
Interaction between interleukin-1β and type-1 cannabinoid receptor is involved in anxiety-like behavior in experimental autoimmune encephalomyelitis 426
Abnormal activity of the Na/Ca exchanger enhances glutamate transmission in experimental autoimmune encephalomyelitis 425
Neuronal vulnerability following inhibition of mitochondrial complex II: a possibile ionic mechanism for Huntington’s disease. 425
Functional connectivity changes within specific networks parallel the clinical evolution of multiple sclerosis 425
Neurophysiology of Parkinson's disease: from basic research to clinical correlates 425
The (endo)cannabinoid system in multiple sclerosis and amyotrophic lateral sclerosis 424
Paroxysmal dysarthria-ataxia syndrome resolving after fingolimod treatment 424
Activation of dopamine D1-like receptors excites LTS interneurons of the striatum 423
Synaptic transmission in the striatum: from plasticity to neurodegeneration 423
Multiparametric MR investigation of the motor pyramidal system in patients with 'truly benign' multiple sclerosis 423
Modulation of monocytes by bioactive lipid anandamide in multiple sclerosis involves distinct Toll-like receptors 423
Interleukin-1β Promotes Long-Term Potentiation in Patients with Multiple Sclerosis 422
Cost-Effectiveness Analysis of Peginterferon Beta-1a In Italian Relapsing Remitting Multiple Sclerosis Management 422
RANTES correlates with inflammatory activity and synaptic excitability in multiple sclerosis 422
The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis. 420
K Index in cerebrospinal fluid: a valid tool in multiple sclerosis diagnosis 420
Heart rate variability is differentially altered in multiple sclerosis: implications for acute, worsening and progressive disability 420
Activation of group III metabotropic glutamate receptors depresses glutamatergic transmission at corticostriatal synapse 419
The (AAT)n repeat of the cannabinoid CB1 receptor gene influences disease progression in relapsing multiple sclerosis. 418
Abnormal sensitivity to cannabinoid receptor stimulation might contribute to altered gamma-aminobutyric acid transmission in the striatum of R6/2 Huntington's disease mice 418
Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study 418
GABAergic signaling and connectivity on Purkinje cells are impaired in experimental autoimmune encephalomyelitis 417
Diagnostic tools for assessment of urinary dysfunction in MS patients without urinary disturbances 417
Striatal synaptic plasticity: implications for motor learning and Parkinson's disease 416
A Substrate Trapping Mutant Form of Striatal-Enriched Protein Tyrosine Phosphatase Prevents Amphetamine-Induced Stereotypies and Long-Term Potentiation in the Striatum 416
Linking synaptopathy and gray matter damage in multiple sclerosis 416
Transcranial direct current stimulation (tdcs) does not produce acute urodynamic changes 415
Determination of κFLC and κ Index in cerebrospinal fluid: a valid alternative to assess intrathecal immunoglobulin synthesis 415
The endocannabinoid system in the inflammatory and neurodegenerative processes of multiple sclerosis and of amyotrophic lateral sclerosis 414
Lack of effect of cannabis-based treatment on clinical and laboratory measures in multiple sclerosis 413
Metabotropic glutamate receptors and striatal synaptic plasticity: implications for neurological diseases 413
Abnormal sensitivity of cannabinoid CB1 receptors in the striatum of mice with experimental amyotrophic lateral sclerosis 412
Abnormal cervical lymph nodes in multiple sclerosis: a preliminary ultrasound study 412
Abnormal brain lateralization and connectivity in schizophrenia 411
TRPV1 channels facilitate glutamate transmission in the striatum 411
Sympathetic autonomic system is differentially altered in progressive and relapsing multiple sclerosis 411
Transcranial direct current stimulation ameliorates tactile sensory deficit in multiple sclerosis 409
Interleukin-8 is associated with acute and persistent dysfunction after optic neuritis 409
D-aspartate prevents corticostriatal long-term depression and attenuates schizophrenia-like symptoms induced by amphetamine and MK-801 408
Interleukin-1β causes excitotoxic neurodegeneration and multiple sclerosis disease progression by activating the apoptotic protein p53 408
rTMS of supplementary motor area modulates therapy-induced dyskinesias in Parkinson disease 407
Excitation by dopamine of rat subthalamic nucleus neurones in vitro-a direct action with unconventional pharmacology 407
Anatomical brain connectivity can assess cognitive dysfunction in multiple sclerosis 407
Cortical plasticity predicts recovery from relapse in multiple sclerosis 407
Observational case-control study of the prevalence of chronic cerebrospinal venous insufficiency in multiple sclerosis: results from the CoSMo study 407
Monomethyl fumarate inhibits the NFkB pathway and pro-inflammatory cytokine expression in microglia through HCA2 signaling via the AMPK/Sirt axis 407
Disability in multiple sclerosis: When synaptic long-term potentiation fails 407
Transient receptor potential vanilloid 1 channels control acetylcholine/2-arachidonoylglicerol coupling in the striatum 406
Inflammation inhibits GABA transmission in multiple sclerosis 406
Immunometabolic profiling of T cells from patients with relapsing-remitting multiple sclerosis reveals an impairment in glycolysis and mitochondrial respiration 406
The brain cytoplasmic RNA BC1 regulates dopamine D2 receptor-mediated transmission in the striatum 405
Disability and its progression can be objectively measured in multiple sclerosis 405
Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia 404
Transcranial magnetic stimulation primes the effects of exercise therapy in multiple sclerosis 404
Cerebrospinal fluid lactate is associated with multiple sclerosis disease progression 404
Identifying neuropathic pain in patients with multiple sclerosis: a cross-sectional multicenter study using highly specific criteria 404
Brain-derived neurotrophic factor controls cannabinoid CB1 receptor function in the striatum 403
Subventricular zone neural progenitors protect striatal neurons from glutamatergic excitotoxicity 403
Synaptic Plasticity and PDGF Signaling Defects Underlie Clinical Progression in Multiple Sclerosis 403
Totale 43.108
Categoria #
all - tutte 314.446
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 314.446


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202024.151 0 0 0 0 0 4.408 3.260 3.592 3.738 3.421 2.809 2.923
2020/202124.409 2.669 3.101 2.579 3.078 2.600 2.315 3.551 2.209 629 472 874 332
2021/20224.756 195 339 187 240 107 673 206 201 428 544 225 1.411
2022/20235.857 747 379 306 631 350 1.511 564 310 403 42 452 162
2023/20241.913 265 72 141 111 164 451 156 99 37 64 33 320
2024/20255.867 361 2.752 1.265 664 499 326 0 0 0 0 0 0
Totale 153.826